Related Experiment Video
Updated: Aug 10, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Insights
Crush syndrome in children following earthquakes leads to high mortality. Infusing plasma with antibodies to endotoxin improved patient outcomes, reducing endotoxemia duration and enhancing recovery in pediatric mass catastrophe casualties.
Area of Science:
- Pediatric critical care medicine
- Trauma and emergency medicine
- Immunology and infectious diseases
Background:
- Crush syndrome significantly increases mortality rates in mass catastrophe casualties.
- Pediatric crush syndrome presents unique challenges in treatment and outcomes.
- Endotoxemia is a critical factor contributing to the severity of crush syndrome.
Purpose of the Study:
- To investigate the efficacy of antibody titer (TA) to endotoxin in treating pediatric crush syndrome.
- To evaluate the impact of plasma infusion with naturally increased TA titer on clinical outcomes.
- To assess the role of endotoxemia in the progression of crush syndrome in children.
Main Methods:
- Studied 18 children (aged 9-14) with crush syndrome post-Armenian earthquake.
- Monitored antibody titer (TA) to endotoxin levels.
- Administered complex therapy and compared outcomes between a control group and an experimental group receiving plasma infusion.
Main Results:
- Children's condition worsened with a threefold reduction in TA levels by day 8 in the control group.
- Experimental group receiving plasma infusion showed improved condition the day after infusion.
- Endotoxemia clinical signs persisted for 10-12 days in the control group, versus rapid improvement in the infused group.
Conclusions:
- Plasma infusion with naturally increased antibody titer to endotoxin is a promising therapeutic approach for pediatric crush syndrome.
- Early intervention with TA-rich plasma can mitigate the severity and duration of endotoxemia.
- This treatment strategy offers a potential method to reduce mortality in mass catastrophe victims with crush injuries.
Abstract:
The crush syndrome developing in casualties in mass catastrophes is the cause of their high mortality rates. We examined 18 children aged from 9 to 14 years with the crush syndrome who suffered during the earthquake in Armenia. Besides other laboratory studies, the test for the titer of antibodies (TA) to endotoxin was performed. Despite the applied complex therapy, the children's condition grew worse on day 8. The TA level reduced threefold. Six patients received a single infusion of plasma with naturally increased TA titer in a dose of 10 ml/kg. On the following day after TA infusion, the condition of children in the experimental group improved, the clinical picture of endotoxemia in the control group persisted for 10-12 days.
Related Concept Videos
Bacterial Gastroenteritis
Cytotoxic Edema: Pathophysiology
Intestinal Obstruction II: Pathophysiology

